Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS)
暂无分享，去创建一个
N. Ikeda | M. Oki | T. Oguri | Y. Iwamoto | Toshiaki Takahashi | N. Yamamoto | K. Nakagawa | S. Sugawara | Y. Fujisaka | N. Katakami | T. Yokoyama | H. Daga | Y. Urata | T. Okamoto | T. Kozuki | Yuki Sato | K. Nishino | Y. Hattori | S. Morita